Entyvio 300 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FGEP5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,284
Award facts
- Contract value 100% obligated
- $29,284.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $29,284.08 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Entyvio 300 mg vials. This delivery order, issued on December 4, 2025, with an ultimate completion date of December 5, 2025, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group is performing this work at its Park Ridge location and will deliver this biologic immunosuppressant medication to support Department of Defense medical supply requirements.
This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was established on November 13, 2025, with a $499.999 billion ceiling value and completion through December 31, 2036. The PPV-G GEN V program represents a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical supply chain support for military healthcare facilities worldwide. Under this vehicle, DLA issues firm fixed-price delivery orders for branded and generic prescription drugs, biologics, and medical consumables. DMS Pharmaceutical Group's established performance on numerous prior delivery orders demonstrates its capability as a critical pharmaceutical supplier within the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FGEP5?
SPE2DR26FGEP5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26FGEP5 worth?
The government has obligated $29,284 on SPE2DR26FGEP5.
Is contract SPE2DR26FGEP5 an order under another contract?
Yes. SPE2DR26FGEP5 is a delivery order under SPE2DR25D9312, an indefinite delivery contract.
Was contract SPE2DR26FGEP5 competed?
The extent of competition for SPE2DR26FGEP5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award